James Singell

James Singell has extensive work experience in marketing and leadership roles. James is currently serving as the Vice President of Marketing at Relmada Therapeutics, Inc since August 2022. Prior to this, they were the Principal Owner of Brencalli, LLC since July 2022. James has also worked at Acacia Pharma Inc., where they held the positions of Vice President of Marketing from April 2020 to August 2022, and Executive Director of Marketing from April 2018 to April 2020. Before joining Acacia Pharma Inc., they worked at Eli Lilly and Company for several years, holding various roles including Director of Market Research, Director of Autoimmune Strategy and Planning, Marketing Director Global New Product Planning, Brand Advisor, Marketing Director Global New Product Planning, Brand Manager, and Sales Manager.

James Singell attended the Thunderbird School of Global Management from 1991 to 1992, where they earned their MBA degree in International Management. Prior to that, from 1985 to 1989, they studied at the University of Colorado Boulder, where they obtained a Bachelor of Arts and Science degree in Communication and Business.